A case of AL amyloidosis presenting with refractory ventricular fibrillation

Teerlink, 2000, Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death, Circulation, 101, 40, 10.1161/01.CIR.101.1.40 John, 2012, Ventricular arrhythmias and sudden cardiac death, Lancet, 380, 1520, 10.1016/S0140-6736(12)61413-5 Falk, 2016, (light-chain) cardiac amyloidosis: a review of diagnosis and therapy, J. Am. Coll. Cardiol., 68, 1323, 10.1016/j.jacc.2016.06.053 Oerlemans, 2019, Cardiac amyloidosis: the need for early diagnosis, Neth. Heart J., 27, 525, 10.1007/s12471-019-1299-1 Desport, 2012, Al amyloidosis, Orphanet J. Rare Dis., 7, 54, 10.1186/1750-1172-7-54 Duhamel, 2017, Incidence and prevalence of light chain amyloidosis: a population-based study, Blood, 130, 5577 Merlini, 2017, AL amyloidosis: from molecular mechanisms to targeted therapies, Hematology Am Soc Hematol Educ Program, 2017, 1, 10.1182/asheducation-2017.1.1 Shah, 2006, Amyloidosis and the heart: a comprehensive review, Arch. Intern. Med., 166, 1805, 10.1001/archinte.166.17.1805 Reisinger, 1997, Electrophysiologic abnormalities in AL (primary) amyloidosis with cardiac involvement, J. Am. Coll. Cardiol., 30, 1046, 10.1016/S0735-1097(97)00267-2 Dubrey, 1998, The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement, Q. J. Med., 91, 141, 10.1093/qjmed/91.2.141 Palladini, 2001, Holter monitoring in AL amyloidosis: prognostic implications, Pacing Clin. Electrophysiol., 24, 1228, 10.1046/j.1460-9592.2001.01228.x Hess, 2004, Out-of-hospital cardiac arrest in patients with cardiac amyloidosis: presenting rhythms, management and outcomes in four patients, Resuscitation, 60, 105, 10.1016/j.resuscitation.2003.08.007 Chung, 2020, Fatal refractory cardiac arrest as presentation of systemic amyloidosis, Respir Med Case Rep, 30, 101042 John, 2018, Arrhythmias in cardiac amyloidosis, J Innov Card Rhythm Manag, 9, 3051, 10.19102/icrm.2018.090301 Sayed, 2015, A study of implanted cardiac rhythm recorders in advanced cardiac AL amyloidosis, Eur. Heart J., 36, 1098, 10.1093/eurheartj/ehu506 Hamon, 2016, Outcome and incidence of appropriate implantable cardioverter-defibrillator therapy in patients with cardiac amyloidosis, Int. J. Cardiol., 222, 562, 10.1016/j.ijcard.2016.07.254 Kristen, 2008, Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death, Heart Rhythm, 5, 235, 10.1016/j.hrthm.2007.10.016 Lin, 2013, Implantable cardioverter defibrillators in patients with cardiac amyloidosis, J. Cardiovasc. Electrophysiol., 24, 793, 10.1111/jce.12123 Varr, 2014, Implantable cardioverter-defibrillator placement in patients with cardiac amyloidosis, Heart Rhythm, 11, 158, 10.1016/j.hrthm.2013.10.026 Al-Khatib, 2017, J. Am. Coll. Cardiol., 72, e91, 10.1016/j.jacc.2017.10.054 Kumar, 2012, Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements, J. Clin. Oncol., 30, 989, 10.1200/JCO.2011.38.5724